Palomar (PLMR) shares ended the last trading session 9.2% higher at $143.13. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.1% loss over the past four weeks.PLMR's shares surged in response to the broader market rally after President Trump announced a 90-day pause of reciprocal tariffs for most countries.This insurance holding company is expected to post quarterly earnings of $1.61 per share in its upcoming repo ...

Company Overview - Carlyle Secured Lending, Inc. (CGBD) shares increased by 8.3% to close at $14.71, following a notable trading volume that exceeded typical levels [1] - The stock had previously experienced a 19.1% decline over the past four weeks [1] Market Influence - The rally in Carlyle Secured Lending's stock was driven by a significant rise in the broader markets, attributed to President Donald Trump's announcement of a 90-day tariff pause for non-retaliating nations, which positively impacted investor sentiment [2] Earnings Expectations - The company is projected to report quarterly earnings of $0.43 per share, reflecting a year-over-year decrease of 20.4% [2] - Expected revenues for the upcoming report are $37.43 million, down 15.2% compared to the same quarter last year [2] Earnings Estimate Trends - The consensus EPS estimate for Carlyle Secured Lending has remained unchanged over the last 30 days, indicating a lack of upward revisions which typically correlate with stock price movements [4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [4] Industry Comparison - Carlyle Secured Lending is part of the Zacks Financial - SBIC & Commercial Industry, where another company, Saratoga Investment (SAR), also holds a Zacks Rank of 3 (Hold) and saw a 7% increase in its last trading session [4][5] - Saratoga Investment's consensus EPS estimate has remained unchanged at $0.77, representing an 18.1% decline from the previous year [5]

Company Overview - DXC Technology Company (DXC) shares increased by 10.4% to close at $15.56, following a broader market rally after US President Donald Trump's announcement to pause reciprocal tariffs for 90 days, although a baseline tariff of 10% on imports remains in effect [1] - The stock had previously experienced a 19.5% loss over the past four weeks [1] Earnings Expectations - DXC is expected to report quarterly earnings of $0.76 per share, reflecting a year-over-year decline of 21.7% [2] - Revenue projections stand at $3.13 billion, which is a decrease of 7.5% compared to the same quarter last year [2] Stock Performance and Trends - The consensus EPS estimate for DXC has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] - DXC currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [3] - ASGN Inc, another company in the same IT services industry, saw an 8.3% increase in its stock price, closing at $61.58, but has returned -20.2% over the past month [3] ASGN Inc Overview - ASGN Inc's consensus EPS estimate has decreased by 1.6% over the past month to $0.95, representing an 18.1% decline from the previous year [4] - ASGN Inc also holds a Zacks Rank of 3 (Hold) [4]

Company Overview - Blue Owl Capital Inc. (OWL) shares increased by 14.3% to close at $18.20, following a significant trading volume compared to normal sessions [1] - The stock had previously experienced a 15.5% decline over the past four weeks [1] Market Influence - The rise in Blue Owl Capital's stock was influenced by a broader market surge, particularly due to President Donald Trump's announcement of a 90-day tariff pause for non-retaliating nations, which positively impacted investor sentiment [2] Earnings Expectations - Blue Owl Capital is projected to report quarterly earnings of $0.20 per share, reflecting a year-over-year increase of 17.7% [2] - Expected revenues for the upcoming report are $645.56 million, representing a 32.7% increase from the same quarter last year [2] Earnings Estimate Trends - The consensus EPS estimate for Blue Owl Capital has remained unchanged over the last 30 days, indicating a lack of upward revisions which typically correlate with stock price movements [4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [4] Industry Comparison - Blue Owl Capital is part of the Zacks Financial - Investment Management industry, where another company, Franklin Resources (BEN), saw an 11.5% increase in its stock price, closing at $18.58 [4] - Franklin Resources has experienced a -15.1% return over the past month, with its EPS estimate for the upcoming report revised down by 5.3% to $0.48, a 14.3% decrease from the previous year [5]

DuPont de Nemours (DD) shares rallied 12.4% in the last trading session to close at $61.95. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 27.8% loss over the past four weeks.DD’s rally is driven by a surge in material stocks after President Trump announced he would pause reciprocal tariffs for 90 days for most countries.This specialty chemicals maker is expected to post quarterly earnings of $0.96 per share ...

Newmont Corporation (NEM) shares rallied 8.4% in the last trading session to close at $48.75. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.6% gain over the past four weeks.NEM's shares rallied on a surge in gold prices on safe-haven demand after President Trump hiked tariffs on China to 125%, stoking fears of deeper trade disruptions. This gold and copper miner is expected to post quarterly earnings of $ ...

Company Overview - Tandem Diabetes Care, Inc. (TNDM) shares increased by 7.6% to close at $17.61, supported by high trading volume, contrasting with an 8.5% decline over the past four weeks [1] - The company is set to release its first quarter 2025 financial results on April 30, which has generated investor optimism [2] Financial Performance - In the fourth quarter, Tandem Diabetes reported a 44% increase in sales and over 25% growth in worldwide pump shipments [2] - The upcoming quarterly loss is expected to be $0.60 per share, reflecting a year-over-year change of +4.8%, with revenues projected at $220.24 million, up 14.9% from the previous year [3] Earnings Estimates - The consensus EPS estimate for the upcoming quarter has remained unchanged over the last 30 days, indicating a lack of recent earnings estimate revisions [4] - Trends in earnings estimate revisions are strongly correlated with near-term stock price movements, suggesting that monitoring TNDM's performance is crucial [4] Industry Context - Tandem Diabetes Care operates within the Zacks Medical - Instruments industry, where another company, Penumbra (PEN), also experienced a 7.7% increase in stock price [4] - Penumbra's consensus EPS estimate has changed by -2% over the past month, with a year-over-year change of +61% [5]

Company Overview - Avient (AVNT) shares increased by 13.7% to close at $32.89, following a significant trading volume compared to normal sessions, despite a 28.1% loss over the past four weeks [1] - The upcoming quarterly earnings for Avient are expected to be $0.76 per share, unchanged from the previous year, with revenues projected at $839.69 million, reflecting a 1.3% increase year-over-year [2] Earnings Estimates and Trends - The consensus EPS estimate for Avient has been revised down by 1.2% over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] - Empirical research suggests that trends in earnings estimate revisions are closely linked to near-term stock price movements, highlighting the importance of monitoring these changes [3] Industry Context - Avient operates within the Zacks Chemical - Diversified industry, which has seen a broader rise in material stocks due to President Trump's decision to pause reciprocal tariffs for 90 days [1] - Another company in the same industry, Dow Inc. (DOW), experienced a 15.7% increase in its stock price, closing at $29.86, despite a significant 29.6% decline over the past month [4] - Dow Inc.'s consensus EPS estimate has dropped by 32% over the past month to $0.04, representing a 92.9% decrease from the previous year's report, and it currently holds a Zacks Rank of 5 (Strong Sell) [5]

Capital One (COF) shares ended the last trading session 14.8% higher at $174.91. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 7.9% loss over the past four weeks.Capital One stock rallied, driven by a massive jump in the broad markets. The jump was attributable to President Donald Trump’s announcement of a 90-day tariff pause for the non-retaliating nations. This cheered the investors, driving the COF stock highe ...

Company Overview - Freeport-McMoRan (FCX) shares increased by 15.5% to close at $33.74, following a notable trading volume, contrasting with an 18.6% loss over the past four weeks [1] - The company is expected to report quarterly earnings of $0.26 per share, reflecting an 18.8% year-over-year decline, with revenues projected at $5.6 billion, down 11.4% from the previous year [2] Earnings Estimates and Trends - The consensus EPS estimate for FCX has been revised 9.4% higher in the last 30 days, indicating a potential for price appreciation [3] - A positive trend in earnings estimate revisions is typically associated with stock price increases, suggesting that FCX may experience further strength [3] Industry Context - FCX operates within the Zacks Mining - Non Ferrous industry, where First Quantum Minerals (FQVLF) also resides, having closed 14% higher at $12.01, despite a -12% return over the past month [3] - For First Quantum Minerals, the consensus EPS estimate has decreased by 37.5% to -$0.07, but represents a 65% change from the previous year's report [4]